Insulin Delivery Devices Market To Reach $28.06 Billion By 2030

 

The global Insulin Delivery Devices Market size was estimated at USD 28.06 billion in 2030 and is expected to grow at a CAGR of 7.89% from 2024 to 2030. Obesity, sedentary lifestyles, and unhealthy food habits, primarily in the young population, lead to the occurrence of diabetes. In addition, the growing diabetic geriatric population is another factor supporting the growth of this vertical. According to the United Nations, Department of Economic and Social Affairs, around 901 million individuals were aged 60 or over in 2015 and this number is projected to increase to 1.4 billion by 2030. Thus, the enlarging elderly population is expected to boost the demand for insulin delivery devices.

Technological innovations and advancements are an ongoing trend in this vertical. The high demand for advanced insulin delivery devices is supporting the adoption of recently launched innovative pen devices and portable pumps, which is estimated to boost the market growth. Also, favorable reimbursement policies for these devices, mainly in developed countries like the U.S. and Germany, are anticipated to fuel the market growth during the study period. However, stringent regulatory requirements regulating the approval of insulin delivery devices and the high cost of insulin analogs in diabetes care management are major factors restraining the growth of this industry.

The market's prominent competitors are taking different initiatives such as acquisition, funding, and product development to expand their product portfolio and enhance their manufacturing capacity. For instance, in October 2021, Eli Lilly partnered with Cipla, to market its Insulin products (Humalog and Trulicity) in India. Additionally, In June 2021, the company acquired Protomer Technologies, to strengthen its market presence. Further, Novo Nordisk, joined hands with Biocorp to develop a Bluetooth-enabled smart add-on device for their pen insulin injector.

List of Key Players in Insulin Delivery Devices Market

• Novo Nordisk A/S
• Sanofi
• Eli Lilly and Company
• Ypsomed AG
• Medtronic
• Insulet Corporation
• B. Braun SE
• Owen Mumford Ltd.
• Tandem Diabetes Care, Inc.
• BD (Becton, Dickinson, and Company)

Request a free sample copy or view the report summary: Insulin Delivery Devices Market Report

Insulin Delivery Devices Market Report Highlights

• The insulin pens segment was the largest revenue-generating category of this market in 2021. The pen is equipped with self-contained cartridges and offers ease in handling and less pain while injecting insulin. The advantages of these pen devices over other products are resulting in their growing popularity, thus serving as a vital factor in contributing to the sectorb s highest share in this market
• The home care segment is estimated to be the fastest-growing segment due to increased adoption of self-care diabetes management devices and the availability of simplified and user-friendly product designs for patients
• North America is the leading regional sector and accounted for the largest revenue share in 2021 primarily due to the favorable reimbursement scenario in this space. Also, the presence of major manufacturers in this region is supporting market growth
• In Asia Pacific, the market is anticipated to grow fast during the forecast period. The high prevalence rate of diabetes in countries, such as China and India, is a major factor contributing to market expansion in this region

Insulin Delivery Devices Market Report Scope

Report Attribute	Details
Market size value in 2024	USD 17.80 billion
Revenue forecast in 2030	USD 28.06 billion
Growth rate	CAGR of 7.89% from 2024 to 2030
Base year for estimation	2023
Actual period	2018 - 2022
Forecast period	2024 - 2030

 

Related Press Release@ Insulin Delivery Devices Industry Analysis

Insulin Delivery Devices Market Segmentation

Grand View Research has segmented the global insulin delivery devices market report based on product, end use, and region.

Insulin Delivery Devices Product Outlook (Revenue, USD Million, 2018 - 2030)

• Insulin Pens
• Reusable Insulin Pens
• Disposable Insulin Pens
• Insulin Pumps
• Patch Pumps
• Tethered Pumps
• Insulin Pen Needles
• Standard Pen Needles
• Safety Pen Needles
• Insulin Syringes
• Other Products

Insulin Delivery Devices End Use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals & Clinics
• Homecare
• Other End Users

Insulin Delivery Devices Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
• U.S.
• Canada
• Mexico
• Europe
• UK
• Germany
• France
• Italy
• Spain
• Denmark
• Sweden
• Norway
• Asia Pacific
• Japan
• China
• India
• Australia
• Thailand
• South Korea
• Latin America
• Brazil
• Argentina
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE
• Kuwait

Explore Horizon, the world's most expansive market research database

Private Nursing Services Market by BAYADA Home Health Care; Maxim Healthcare Services; NurseRegistry; Aveanna Healthcare LLC; Homage Sdn. Bhd.

The global Private Nursing Services Market size is anticipated to reach USD 7.37 billion by 2030, expanding at a CAGR of 5.85% from 2024 to 2030, according to a new report by Grand View Research, Inc. Private nurses provide medical care such as administering medications, managing wounds, and monitoring vital signs to the patients suffering from chronic diseases. They also offer emotional support and help with daily tasks like bathing and dressing. Thus, the increasing prevalence of chronic diseases is anticipated to drive the need for private nursing services over the forecast period.

According to the statistics from the American Cancer Society published in 2023, 1,918,030 new cancer cases were diagnosed in 2022. It is estimated that approximately 1,958,310 new cancer cases were diagnosed in the U.S. in 2023, which is equivalent to 5,370 new cases per day. Due to cancer treatments being long-term and expensive at hospital facilities, the increasing cancer burden in the U.S. is anticipated to require more nursing care, which is expected to drive the market's growth.

Furthermore, the COVID-19 pandemic had a significant impact on private duty nursing (PDN) services, particularly for children with medical complexities (CMC). In a study conducted by the Center for Research in Education and Social Policy in September 2021, it was found that 32% of shifts were not covered in the six months prior to the pandemic, compared to the period of January-June 2021. This was reported by family caregivers of CMC. This shortage of PDNs led to difficulties in securing PDNs for CMC care, with 44% of family caregivers reporting difficulty in securing PDNs. In addition, the same study reported that 71% of PDNs altered their work schedules during the pandemic, citing reasons such as increased workload, fear of infection, and family obligations. However, with a decrease in COVID-19 cases, the market has since recovered and is likely to increase rapidly in the post-pandemic period.

List of Key Players in the Private Nursing Services Market

• BAYADA Home Health Care
• Maxim Healthcare Services
• NurseRegistry
• Aveanna Healthcare LLC
• Homage Sdn. Bhd
• Private Nursing Care
• Curantis Private Nursing services LLC
• CK Franchising, Inc.
• Providence
• Private Nurse ApS
• Active Global Specialised Caregivers Pte Ltd
• Red Crowns
• ATLANTIC CARE SERVICES
• Sublime Nursing
• Private Duty Nursing in an Acute Hospital

Request a free sample copy or view report summary: Private Nursing Services Market Report

Private Nursing Services Market Report Highlights

• Based on medical condition, the chronic disease management segment held the largest market share in 2023. However, post-operative services are the fastest-growing segment during the forecast period
• Based on type, the medical care segment accounted for the largest market share in 2023. The growing incidence of chronic diseases such as COPD and asthma, as well as the cost benefits of home care devices and services compared to hospital visits, are the primary factors driving the growth of the medical care segment in the private nursing services market
• North America dominated the market in 2023 due to factors such as the aging population, increasing demand for personalized care, and the rise in development of healthcare infrastructure
• In the U.S., a rise in disposable income is expected to drive market growth. For instance, according to Trading Economic Data published in 2023, disposable personal income increased to USD 19,742.3 billion in April 2023 from USD 18,384.3 billion in April 2022. This growth in disposable income may lead to increased spending on healthcare, which is likely to contribute to market growth

Private Nursing Services Market Report Scope

Report Attribute	Details
Market size value in 2024	USD 5.24 billion
Revenue forecast in 2030	USD 7.37 billion
Growth Rate	CAGR of 5.85% from 2024 to 2030
Actual data	2018 - 2023
Forecast period	2024 - 2030

 

Related Press Release@ Private Nursing Services Industry Analysis

Private Nursing Services Market Segmentation

Grand View Research has segmented the global private nursing services market based on medical condition, type, and region:

Private Nursing Services Medical Condition Outlook (Revenue, USD Million, 2018 - 2030)

• Chronic Disease Management
• Post Operative Services
• Elderly Care
• Pediatric Care
• Others

Private Nursing Services Type Outlook (Revenue, USD Million, 2018 - 2030)

• Medical Care
• Non-Medical Care

Private Nursing Services Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
• U.S.
• Canada
• Mexico
• Europe
• UK
• Germany
• France
• Italy
• Spain
• Sweden
• Denmark
• Norway
• Asia Pacific
• Japan
• China
• India
• Australia
• Thailand
• South Korea
• Singapore
• Latin America
• Brazil
• Argentina
• MEA
• South Africa
• Saudi Arabia
• UAE
• Kuwait

Explore Horizon, the world's most expansive market research database

About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com

Microcarriers Market by Thermo Fisher Scientific, Inc.; Sartorius AG; Merck KGaA; Danaher Corporation; HiMedia Laboratories Pvt. Ltd.

 

The global microcarriers market size is expected to reach USD 3.71 billion by 2030, registering a CAGR of 11.53% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 11.6% from 2022 to 2030. The growth of the market is driven by the rising demand of cell-cultured products, the growing burden of diseases worldwide, constant investments for intensive R&D activities to identify and develop new treatments for rare disorders, and the continuous developments in technologies employed in advanced research such as cell-biology.4

Amidst the COVID-19 pandemic, the market witnessed a positive growth. The continuous strive of scientist and researchers to find and develop vaccines for the SARS-CoV2 virus resulted in scaling up of R&D efforts by both healthcare companies and academic institutes. The increased research activities, huge funding, and growing demand of therapeutic products resulted in the growth of the market. Moreover, development of viral vectors based vaccines requires efficient production of viruses which is possible using microcarriers cell-culture. For instance, scientists from University of Copenhagen demonstrated in their research article published in June 2021 that SARS-CoV2 virus was efficiently produced in Vero cells in a single-use bioreactors packed with carrier beads. Findings like these have boosted the COVID-19 vaccine production further propelling market growth.

Moreover, the marketspace is rapidly expanding owing to the high usage of microcarriers as matrix for adherent cell manufacturing and these small spherical beads are used across all scales of commercial production. The increasing demand of innovative therapeutic options such as cell and gene therapy, viral vaccines, and monoclonal antibodies for treatment of malignant and rare diseases has resulted in increase in the biopharmaceutical production capacities. For example, Pfizer Inc., announced in December 2021 that it has invested USD 68.5 million and opened a new facility in North Carolina, USA. With the expansion the company is focused on enhancing its gene therapy capabilities and clinically develops its portfolio for hemophilia A and B, DMD (Duchenne muscular dystrophy), ALS (amyotrophic lateral sclerosis) and many more neurologic, endocrine as well as metabolic diseases. Such increased investments for development of biopharmaceuticals and regenerative medicines are expected to propel the market growth.

Furthermore, cell-biology based research involves exhaustive R&D for developing new therapies. But these efforts require investments for cell lines, media, equipment and other related products for microcarriers culture and thus requires huge influx of money. Institutes and emerging players with budget constraints will limit the cell based research for therapeutics development. Hence, it will decrease the adoption of cell-culture products and restrain the growth. However, government initiatives for novel drug production and collaboration & partnerships with key players can offer investment relief and enhance the market growth.

List of Key Players in the Microcarriers Market

• Thermo Fisher Scientific, Inc.
• Merck KGaA
• Danaher Corporation
• Sartorius AG
• Corning Incorporated
• Eppendorf SE
• Bio-Rad Laboratories, Inc.
• HiMedia Laboratories Pvt. Ltd.
• denovoMATRIX GmbH

Request a free sample copy or view report summary: Microcarriers Market Report

Microcarriers Market Report Highlights

• By consumables, the microcarrier beads was identified as the largest contributor with a 70.1% share of the market in 2023. Presence of key players offering the products along with their continuous usage during bio-manufacturing process drives market growth
• By application, the biopharmaceutical production segment is anticipated to grow significantly over the forecast period. Increased demand for vaccine during the COVID-19 pandemic and continuous regulatory support for therapeutics boosts the usage of microcarriers during bio-manufacturing, leading to highest segment share
• The contract research organizations (CROs) & contract manufacturing organizations (CMOs) segment captured the largest market share at 40.3% in 2023. The increasing demand for outsourcing services in the pharmaceutical and biotechnology industries drives this segment.
• North America generated the highest revenue with a 36.7% share in 2023. The major factors for the regional dominance are prevalence of diseases, presence of key market players, high usage of cell based products, and supportive government initiatives
• Asia Pacific region will witness the fastest growth in the microcarriers market during the forecast, due to rising R&D activities, increased domestic demand of biologics and growing economies

Microcarriers Market Report Scope

Report Attribute	Details
Market size value in 2024	USD 1.93 billion
Revenue forecast in 2030	USD 3.71 billion
Growth rate	CAGR of 11.53% from 2024 to 2030
Base year for estimation	2023
Historical data	2018 - 2022
Forecast period	2024 - 2030

 

Microcarriers Market Segmentation

Grand View Research has segmented the global microcarriers market on the basis of on consumable, application, end-use and region:

Microcarriers Consumable Outlook (Revenue, USD Million, 2018 - 2030)

• Media & Reagents
• Microcarrier Beads

Microcarriers Application Outlook (Revenue, USD Million, 2018 - 2030)

• Biopharmaceutical Production
• Regenerative Medicine

Microcarriers End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Pharmaceutical & Biotechnology Companies
• Contract Research Organizations & Contract Manufacturing Organizations
• Academic & Research Institutes

Microcarriers Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
• U.S.
• Canada
• Mexico
• Europe
• UK
• Germany
• France
• Italy
• Spain
• Denmark
• Sweden
• Norway
• Asia Pacific
• Japan
• China
• India
• Australia
• South Korea
• Thailand
• Latin America
• Brazil
• Argentina
• Middle East and Africa (MEA)
• South Africa
• Saudi Arabia
• UAE
• Kuwait

Explore Horizon, the world's most expansive market research database

About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com